NCT00252512

Brief Summary

Contingency management interventions involve providing a tangible reward for progress toward treatment goals. The purpose of this study is to determine whether a contingency management intervention added to usual care leads to improved attendance and decreased substance use in patients attending outpatient substance use disorders treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
332

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2007

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 9, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 11, 2005

Completed
1.5 years until next milestone

Study Start

First participant enrolled

May 1, 2007

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2010

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2010

Completed
4.6 years until next milestone

Results Posted

Study results publicly available

August 29, 2014

Completed
Last Updated

August 16, 2018

Status Verified

July 1, 2018

Enrollment Period

2.7 years

First QC Date

November 9, 2005

Results QC Date

August 18, 2014

Last Update Submit

July 19, 2018

Conditions

Keywords

Contingency management interventionsSubstance use disorders treatmentTreatment effectivenessRandomized clinical trialBehavioral research

Outcome Measures

Primary Outcomes (1)

  • Number of Negative Breath Alcohol and Urine Drug Screens Out of Possible 16

    8 weeks

Secondary Outcomes (5)

  • Psychiatric Status

    8 weeks, 6 months, 12 months

  • VHA Healthcare Service Utilization

    Baseline to 6 month follow up and 6 month follow up to 12 month follow up.

  • Housing

    8 week, 6 month and 12 month follow-ups

  • Legal Status

    8 weeks, 6 month and 12 month follow ups

  • Employment Status

    8 week, 6 month and 12 month follow up

Study Arms (2)

Contingency Management

EXPERIMENTAL

Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are negative, they receive a chance to draw tokens from a bowl. Some tokens are social reinforcement. Others have monetary value.

Behavioral: Contingency Management

Placebo

PLACEBO COMPARATOR

Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.

Other: Placebo

Interventions

Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are both negative, the participant receives a chance to draw tokens from a bowl. Some tokens are social reinforcement (Good Job!). Other have monetary value.

Contingency Management
PlaceboOTHER

Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.

Placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • veterans presenting for outpatient substance use disorders treatment with a diagnosis of alcohol, cocaine, amphetamine, or methamphetamine dependence

You may not qualify if:

  • primary cannabis dependence
  • primary opioid dependence
  • severe psychiatric symptoms
  • suicide risk
  • positive history or screen for pathological gambling
  • lacking transportation or living too far away to attend twice per week research appointments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Minneapolis VA Health Care System, Minneapolis, MN

Minneapolis, Minnesota, 55417, United States

Location

VA Puget Sound Health Care System Seattle Division, Seattle, WA

Seattle, Washington, 98108, United States

Location

Related Publications (3)

  • Hagedorn HJ, Noorbaloochi S, Simon AB, Bangerter A, Stitzer ML, Stetler CB, Kivlahan D. Rewarding early abstinence in Veterans Health Administration addiction clinics. J Subst Abuse Treat. 2013 Jul;45(1):109-17. doi: 10.1016/j.jsat.2013.01.006. Epub 2013 Feb 28.

  • Hagedorn HJ, Stetler CB, Bangerter A, Noorbaloochi S, Stitzer ML, Kivlahan D. An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers. Addict Sci Clin Pract. 2014 Jul 9;9(1):12. doi: 10.1186/1940-0640-9-12.

  • Hagedorn HJ, Noorbaloochi S, Bangerter A, Stitzer ML, Kivlahan D. Health care cost trajectories in the year prior to and following intake into Veterans Health Administration outpatient substance use disorders treatment. J Subst Abuse Treat. 2017 Aug;79:46-52. doi: 10.1016/j.jsat.2017.05.013. Epub 2017 May 25.

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Results Point of Contact

Title
Hildi Hagedorn
Organization
Minneapolis VA Health Care System

Study Officials

  • Hildi J. Hagedorn, PhD

    Minneapolis VA Health Care System, Minneapolis, MN

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 9, 2005

First Posted

November 11, 2005

Study Start

May 1, 2007

Primary Completion

January 1, 2010

Study Completion

February 1, 2010

Last Updated

August 16, 2018

Results First Posted

August 29, 2014

Record last verified: 2018-07

Locations